Volume 2, Number 2, October-November-December 2009

Lipids on trial: By focusing on total cholesterol alone, primary care is guilty of not going far enough to address cardiovascular residual risk
The development of this supplement is supported by a grant from Merck Sharp & Dohme Limited (MSD) and is based upon a symposium held at the PCCS Conference 2008 which was sponsored by MSD

View full PDF article (open in new window)
Email this article